Volume 5, Issue 1

January/February 2005

Pain Management

Selection Criteria for Intrathecal Opioid Therapy: A Re-examination of the "Science"

Michael E. Schatman, PhD, DAAPM
Journal Article
17 Min Read

A survey of the "science" behind exclusionary psychological assessment finds that supporting empirical data is virtually non-existent and may be unduly limiting access to those patients for whom this treatment represents their only chance for comfort and a reasonable quality of life.

Pain Management

Selection Criteria for Intrathecal Opioid Therapy: A Re-examination of the "Science"

Michael E. Schatman, PhD, DAAPM
Journal Article
17 Min Read

A survey of the "science" behind exclusionary psychological assessment finds that supporting empirical data is virtually non-existent and may be unduly limiting access to those patients for whom this treatment represents their only chance for comfort and a reasonable quality of life.

The one drug class that has the optimum profile to manage severe, unremitting, intractable pain—opioids—is often shunned due to social stigma, lack of dosing guidelines, misunderstanding of side effects (addiction, respiratory depression), and a pervasive
Pain Management

‘Opiophobia’ Past and Present

Bruce R. Moldovan, JD
Journal Article
24 Min Read

The one drug class that has the optimum profile to manage severe, unremitting, intractable pain—opioids—is often shunned due to social stigma, lack of dosing guidelines, misunderstanding of side effects (addiction, respiratory depression), and a pervasive fear of unwarranted regulatory persecution.

The one drug class that has the optimum profile to manage severe, unremitting, intractable pain—opioids—is often shunned due to social stigma, lack of dosing guidelines, misunderstanding of side effects (addiction, respiratory depression), and a pervasive
Pain Management

‘Opiophobia’ Past and Present

Bruce R. Moldovan, JD
Journal Article
24 Min Read

The one drug class that has the optimum profile to manage severe, unremitting, intractable pain—opioids—is often shunned due to social stigma, lack of dosing guidelines, misunderstanding of side effects (addiction, respiratory depression), and a pervasive fear of unwarranted regulatory persecution.